AMIKO

AMIKO Develops Advanced Sensor Technology and AI-Based Mobile Health Solutions to Assist Healthcare Professionals and Enable Better Patient Outcomes.Founded in 2015 and headquartered in central London, with an ISO 13485 certified R&D lab in Milan, AMIKO today serves commercial, institutional, and individual customers across Italy, Germany, France, Spain, the UK, and the Netherlands. The company is growing into a global provider of advanced therapy data and digital disease management services, enabling a shared vision of digital health for patients, healthcare professionals, and payers alike. AMIKO offers Respiro, a digital medicine platform that works with connected inhalers, combining data, artificial intelligence, and an elegant digital experience to elevate respiratory care.